Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma

Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.

Related Keywords

Vadodara ,Gujarat ,India ,Zydus Lifesciences ,Drug Administration ,Zydus Gets ,Levothyroxine Sodium ,Sodium Injection ,Business ,Us Health Regulator ,Generic Product ,